Table 1.
Baseline characteristics and blood pressure (BP) of 4,412 patients with hypertension with and without VKA Treatment
| VKA group n = 569 | Control group n = 3,843 | p-value** | |
|---|---|---|---|
| Age, years (SD) | 76.7 (10.0) | 67.8 (13.8) | <0.01 |
| Men, % | 47.6 | 52.4 | 0.044 |
| Consultations/year, n (SD) | 10.9 (7.2) | 6.6 (5.5) | <0.01 |
| Chronic conditions, n (SD) | 3.8 (2.5) | 3.1 (2.3) | <0.01 |
| Coronary heart disease, n (%) | 45 (7.9) | 224 (5.8) | 0.053 |
| Heart failure, n (%) | 28 (4.9) | 50 (1.3) | <0.01 |
| Atherosclerosis, n (%) | 28 (4.9) | 80 (2.1) | <0.01 |
| Obesity, n (%) | 20 (3.5) | 235 (6.1) | 0.01 |
| Diabetes, n (%) | 87 (15.3) | 557 (14.5) | 0.62 |
| Mean systolic BP, mm Hg (SD) | 130.6 (14.9) | 139.8 (15.8) | <0.01 |
| Mean diastolic BP, mm Hg (SD) | 76.6 (7.9) | 81.3 (9.3) | <0.01 |
| Patients with controlled* BP, % | 74.9 | 49.4 | <0.01 |
*defined as blood pressure <140/90 mmHg
**p-value: Results of univariate comparisons between groups based on unpaired t-test or Chi-square test as appropriate